Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
TDb Split Corp 5.25% PRF REDEEM 01/12/2029 CAD 10	XTD.PR.A	21. nov 2024	10.21	-0.39
TDG Gold Corp.	TDG	21. nov 2024	0.12	-4.00
Tearlach Resources Limited	TEA	21. nov 2024	0.02	0.00
Teck Resources	TECK.B	21. nov 2024	65.97	+1.10
Teck Resources Ltd	TECK.A	21. nov 2024	66.55	+0.30
Tecsys Inc	TCS	21. nov 2024	44.28	-0.76
Tectonic Metals Inc	TECT	21. nov 2024	0.05	0.00
Telesat	TSAT	21. nov 2024	16.06	+3.68
Telo Genomics Corp	TELO	21. nov 2024	0.12	+4.35
Telus	T	21. nov 2024	21.38	-1.34
Telus International	TIXT	21. nov 2024	5.01	+2.66
Tenaz Energy Corp	TNZ	21. nov 2024	14.96	-1.58
Tenth Avenue Petroleum Corp	TPC	21. nov 2024	0.08	0.00
TeraGo Inc.	TGO	21. nov 2024	1.36	-4.90
TerrAscend Corp	TSND	21. nov 2024	1.08	-0.92
TerraVest Industries Inc	TVK	21. nov 2024	119.44	-1.65
Tesoro Minerals Corp	TES	21. nov 2024	0.03	0.00
Tethys Petroleum Limited	TPL	21. nov 2024	1.55	-3.13
Teuton Resources Corp.	TUO	21. nov 2024	1.12	+0.90
TFI International	TFII	21. nov 2024	206.89	+2.40
TGX Energy & Resources Inc.	TGX	21. nov 2024	0.05	0.00
Themac Resources Group Limited	MAC	21. nov 2024	0.03	0.00
Theralase Technologies Inc.	TLT	21. nov 2024	0.29	+1.75
Theratechnologies	TH	21. nov 2024	1.68	-1.18
Thermal Energy International Inc	TMG	21. nov 2024	0.20	0.00
Thesis Gold Inc	TAU	21. nov 2024	0.64	-3.03
Thinkific Labs Inc	THNC	21. nov 2024	2.82	-1.05
Thiogenesis Therapeutics Corp	TTI	21. nov 2024	0.68	0.00
Thomson Reuters	TRI	21. nov 2024	226.18	+0.71
Thomson-Reuters Corp FR PRF PERPETUAL CAD 25 - Ser II	TRI.PR.B	21. nov 2024	13.85	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.